Methyl CpG-Binding Protein 2 (a Mutation of Which Causes Rett Syndrome) Directly Regulates Insulin-Like Growth Factor Binding Protein 3 in Mouse and Human Brains
Authors:
Open Access
- 1 February 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Neuropathology & Experimental Neurology
- Vol. 66 (2) , 117-123
Abstract
Rett syndrome (RTT) is a major neurodevelopmental disorder, characterized by mental retardation and autistic behavior. Mutation of the MeCP2 gene, enKeywords
This publication has 29 references indexed in Scilit:
- Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndromeHuman Molecular Genetics, 2005
- Integrative analysis of the cancer transcriptomeNature Genetics, 2005
- Another Patient With MECP2 Mutation Without Classic Rett Syndrome PhenotypePediatric Neurology, 2005
- Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3Human Molecular Genetics, 2004
- The Second Workshop on Methylation and Child Neurology—Methylation, Epigenetics and the Nervous System April 20, 2003, Hongo, Tokyo, JapanBrain and Development, 2004
- Mechanisms underlying lack of insulin-like growth factor-binding protein-3 expression in non-small-cell lung cancerOncogene, 2004
- Derepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2Science, 2003
- Analysis of Chromatin-Immunopurified MeCP2-Associated FragmentsBiochemical and Biophysical Research Communications, 2001
- Phenotypic Manifestations of Insulin-Like Growth Factor-Binding Protein-3 Overexpression in Transgenic MiceEndocrinology, 2001
- Angelman syndrome phenotype associated with mutations inMECP2, a gene encoding a methyl CpG binding proteinJournal of Medical Genetics, 2001